BIOMAT Database Logo BIOMAT Database Logo

Follow-up study of anti-hepatitis C virus antibodies in blood donors implicated in post-transfusion non-A, non-B hepatitis. 1993

T Mazda, and K Nakata, and M Bannai, and T Miyamura, and J Chiba, and H Ohba, and Y Kaminuma, and T Katayama
Japanese Red Cross Tokyo Metropolitan Blood Center.

We retrospectively examined the antibodies to p22, a hepatitis C virus (HCV) nucleocapsid protein, and to c100-3, a HCV nonstructural protein, in donors whose blood was transfused to patients who later developed post-transfusion non-A, non-B hepatitis. Of 13 such blood donors, three seroconverted and three seroreverted with the anti-c100-3 test. In contrast, 12 of the 13 blood donors showed the same results at transfusion and follow-up, and one donor showed seroconversion with the anti-p22 assay. The follow-up study shows that the anti-p22 antibody test provides consistent results and is far more suitable for screening blood than the anti-c100-3 test.

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005188 False Negative Reactions Negative test results in subjects who possess the attribute for which the test is conducted. The labeling of diseased persons as healthy when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Negative Reaction,Reaction, False Negative,Reactions, False Negative
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis

Related Publications

T Mazda, and K Nakata, and M Bannai, and T Miyamura, and J Chiba, and H Ohba, and Y Kaminuma, and T Katayama
Hepatitis C virus RNA in symptomless donors implicated in post-transfusion non-A, non-B hepatitis.
August 1990, Lancet (London, England),
T Mazda, and K Nakata, and M Bannai, and T Miyamura, and J Chiba, and H Ohba, and Y Kaminuma, and T Katayama
Hepatitis C virus among blood donors: follow-up study.
June 1994, Transfusion,
T Mazda, and K Nakata, and M Bannai, and T Miyamura, and J Chiba, and H Ohba, and Y Kaminuma, and T Katayama
Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands.
August 1989, Lancet (London, England),
T Mazda, and K Nakata, and M Bannai, and T Miyamura, and J Chiba, and H Ohba, and Y Kaminuma, and T Katayama
Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis.
November 1992, Journal of hepatology,
T Mazda, and K Nakata, and M Bannai, and T Miyamura, and J Chiba, and H Ohba, and Y Kaminuma, and T Katayama
Follow up of blood donors positive for antibodies to hepatitis C virus.
March 1994, BMJ (Clinical research ed.),
T Mazda, and K Nakata, and M Bannai, and T Miyamura, and J Chiba, and H Ohba, and Y Kaminuma, and T Katayama
Incidence of anti-hepatitis C virus antibodies in non-A, non-B post-transfusion hepatitis in an area of northern Italy.
January 1991, Infection,
T Mazda, and K Nakata, and M Bannai, and T Miyamura, and J Chiba, and H Ohba, and Y Kaminuma, and T Katayama
[Medical follow-up of blood donors with hepatitis C virus antibodies. Value of transfusion surveys for the recipients].
January 1996, Gastroenterologie clinique et biologique,
T Mazda, and K Nakata, and M Bannai, and T Miyamura, and J Chiba, and H Ohba, and Y Kaminuma, and T Katayama
Post-transfusion non-A, non-B hepatitis: significance of raised ALT and anti-HBc in blood donors.
January 1989, Vox sanguinis,
T Mazda, and K Nakata, and M Bannai, and T Miyamura, and J Chiba, and H Ohba, and Y Kaminuma, and T Katayama
Post-transfusion non-A, non-B hepatitis: significance of raised ALT and anti-HBc in blood donors.
January 1988, Vox sanguinis,
T Mazda, and K Nakata, and M Bannai, and T Miyamura, and J Chiba, and H Ohba, and Y Kaminuma, and T Katayama
A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan.
December 1989, Nucleic acids research,
Copied contents to your clipboard!